The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories
Author(s) -
Massimo Milione,
Patrick Maisonneuve,
Francesca Spada,
Alessio Pellegrinelli,
Paola Spaggiari,
Luca Albarello,
Eleonora Pisa,
Massimo Barberis,
Alessandro Vanoli,
Roberto Buzzoni,
Sara Pusceddu,
Laura Concas,
Fausto Sessa,
Enrico Solcia,
Carlo Capella,
Nicola Fazio,
Stefano La Rosa
Publication year - 2016
Publication title -
neuroendocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.493
H-Index - 101
eISSN - 1423-0194
pISSN - 0028-3835
DOI - 10.1159/000445165
Subject(s) - cd117 , proliferation index , ki 67 , proportional hazards model , univariate analysis , pathology , medicine , proliferative index , neuroendocrine differentiation , stage (stratigraphy) , survival analysis , neuroendocrine tumors , multivariate analysis , oncology , gastroenterology , immunohistochemistry , biology , cancer , cd34 , paleontology , genetics , stem cell , prostate cancer
Gastroenteropancreatic (GEP) neuroendocrine carcinomas (NECs) are defined as neuroendocrine neoplasms (NENs) with a Ki-67 index >20% according to the 2010 WHO classification. Some reports suggest that this category is heterogeneous. We retrospectively studied a series of 136 patients affected by grade 3 GEP-NECs with the aim to clarify the prognostic role of tumor morphological differentiation, proliferation, defect in mismatch repair proteins (MMRd), CD117 expression, and site of origin. The primary endpoint was the correlation between these parameters and the overall survival (OS).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom